Donald Pearson is an Investment and Portfolio Analyst for Pearson Capital, Inc. His corporate background includes twenty-plus years of marketing and financial experience, while teaching 401k application and personal portfolio management. Today he conducts educational seminars on how to structure investments to include portfolio diversification and management, IRA’s (Roth, Traditional, College) SEP’s, KEOGH’s, CD’s, Bond’s, 401k (including before and after tax contributions, how, when and why to roll over, when to begin withdrawals), short-and long -ange goal setting, retirement planning, understanding risk versus reward, and asset growth versus inflation.
Articles by Donald Pearson
This pharmacy benefit management company beat analysts’ estimates by $0.03 last quarter. Three analysts have increased their EPS estimates for the company in the last 30 days.
The top five holdings of this well-diversified ETF are AT&T Inc (T, 2.00% of net assets); People's United Financial Inc (PBCT, 2.00%); HCP Inc (HCP, 2.00%); Chevron Corp (CVX, 1.86%) and Nucor Corp (NUE, 1.60%). The ETF has a dividend yield of 2.30%, quarterly.
Institutions have recently added 14.9 million shares of this tech goliath to their holdings. Of the company’s 13 analysts, 12 rate the stock a “Buy”; four have increased their EPS projections in the past month; and the company beat last quarter’s earnings estimates fourteen...
Today, Pearson Investment Letter Editor Donald Pearson recommends a 4%-yielding health care stock.
“Merck & Co., Inc. (MRK, $43) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health and consumer care products, which it directly...